A variety of immunosuppressive checkpoints such as PD-1/PD-L1, CD47/SIRPα, TIM3, and CTLA4 are expressed on the surface of both chordoma cells and immune cells, and ICIs are the most widely performed strategy in the field of chordoma immunotherapy. This evidence concerns the gene CD274 and chordoma.